Maternal exposure to benzene from gasoline and other petroleum-derived sources is associated with subsequent development of childhood leukaemia in the offspring, according to the findings in this prospective study, with the exposure metric defined a priori.
Use of bevacizumab in combination with temozolomide yields no survival gains when compared with temozolomide alone in the treatment of patients with grade 2–3 glioma, according to the results of the open-label phase II TAVAREC trial.
High-risk human papillomavirus (hrHPV) appears to improve cancer prognoses, such that women with hrHPV-positive cervical tumours have better survival than those negative for the infection, a recent study has found.
Treatment with tumour necrosis factor inhibitor (TNFi) does not carry a heightened risk of cancer recurrence in patients with rheumatoid arthritis (RA) and a history of cancer, as shown in a recent study.
Oral factor Xa inhibitors may be used as potential substitutes for warfarin and low molecular weight heparin for the prevention of recurrent thromboembolism in oncology patients, suggests a recent study. However, randomized controlled trials are warranted to confirm these results.
Prognostic nutrition index (PNI) strongly predicts clinical outcomes in patients with locally advanced non-small-cell lung cancer (NSCLC), according to two studies presented at the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer (WCLC 2018).